Hatchtech Pty Ltd is an innovative biotechnology company developing novel solutions for everyday health problems based in Melbourne, Australia. Its lead development product, Xeglyze™, is a single dose, single treatment, topical prescription product for the control of head lice. Xeglyze was approved by the FDA in July 2020 and is currently available for partnering.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Suite 201, 697 Burke Rd, Camberwell,victoria,australia
- Phone
- 61 3 8344 3189
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- hatchtech.com.au
- Keywords
- Specialist | Sales….
- HQ
- Camberwell, Victoria
Hatchtech Pty Ltd Questions
Hatchtech Pty Ltd's helpline number is 61 3 8344 3189
Hatchtech Pty Ltd's website is hatchtech.com.au
Hatchtech Pty Ltd's LinkedIn profile is https://au.linkedin.com/company/hatchtech-pty-ltd
Hatchtech Pty Ltd has
5 employees.
View email and phone details for 5
employees at Hatchtech Pty Ltd.
Hatchtech Pty Ltd's industry is
Biotechnology Research
Hatchtech Pty Ltd's top competitors are
Smart Sparrow (Acq 2020),
Tw3,
Kinoxis Therapeutics Pty Ltd,
Aurtra (Acquired Schneider Electric),
Servatus Ltd,
Ausbiotech,
Avecho Biotechnology Limited,
Starpharma,
Anudha Limited,
Dimerix Limited.
Hatchtech Pty Ltd's categories are Biotechnology Research
Hatchtech Pty Ltd's founding year is 2002
